Therapeutic plasma exchange in Amatoxin-associated paediatric acute liver failureāresults from the Amanita-PEX study
The retrospective multicentre Amanita-PEX study examined outcomes and the role of therapeutic plasma exchange in children with amatoxin-associated acute liver failure.
Amplification of genetic and metabolic factors in alpha-1 antitrypsin deficiency
A study links obesity and diabetes to worse liver outcomes in adults with Pi*ZZ alpha-1 antitrypsin deficiency, highlighting the combined impact of genetic and metabolic risk factors.
Patient pathways for rare liver diseases: a European template developed by ERN RARE-LIVER
ERN RARE-LIVER has developed a European framework for patient-centred pathways, translating clinical recommendations and patient priorities into coordinated care.
EASL Clinical Practice Guidelines on vascular diseases of the liver
A new 2025 EASL guideline outlines expert recommendations for the diagnosis and management of major vascular liver diseases, emphasising early detection, stepwise treatment strategies, and multidisciplinary care.
Therapeutic plasma exchange in amatoxin associated acute liver failure-results from the multi-center Amanita-PEX study
A multicentre study analyzed patients with amatoxin-induced acute liver failure from 25 centers between 2013 and 2024, comparing therapeutic plasma exchange with standard-of-care treatment.
Trends in Primary Biliary Cholangitis: Prospective Cohort Study From the European Reference Network Registry (R-LIVER)
Real-world data from the ERN RARE LIVER registry highlight current practices in PBC management and reveal opportunities to optimise care for higher-risk patients.